Both eplazole and rabeprazole are proton pump inhibitors. As for which one is more effective, it is related to the patient’s age of onset, drug sensitivity, etc., and cannot be generalized, and can be used in accordance with medical advice.
Epprazole commonly used tablets, the treatment of duodenal ulcer, ulcerative bleeding, reflux esophagitis, etc. The efficacy of the treatment is clear, the common adverse reactions are headache, dizziness, diarrhea, serum aminotransferase elevation, abdominal distension, dry mouth, etc., prohibited in the composition of the allergy.
Rabeprazole is a tablet, used for gastric ulcer, reflux esophagitis, duodenal ulcer, anastomotic ulcers, etc. The efficacy is clear, there will be rash, nausea, diarrhea, vomiting, abdominal distension, plenum hematopoiesis, hepatic dysfunction, etc., is prohibited for those who are allergic to the ingredients, hepatic function impairment.
The therapeutic effect of both eplazole and rabeprazole is clear. The therapeutic effect of the drug is related to the patient’s age of onset, sensitivity to the drug, previous use of medication and so on, can not be generalized, should be used under the guidance of a doctor.